Neurotrack's competitors

Neurotrack's competitors include AbleTo, Advance Health, EXACT Sciences and bioMerieux
Add company...
Neurotrack
Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur.
AbleTo
AbleTo is a technology-enabled provider of mental health care.
Advance Health
Advance Health provides industry leading managed care prospective health solutions.
EXACT Sciences
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
bioMerieux
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Founding Date
Founding Date
2012
Founding Date
2008
Founding Date
2011
Founding Date
1995
Founding Date
1963
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Redwood City, US HQ
Locations
New York, US HQ
Locations
Chantilly, US HQ
Richmond, US
Rapid City, US
Locations
Madison, US HQ
Locations
Marcy-l'Étoile, FR HQ
Employees
Employees
23 4% decrease
Employees
202
Employees
372 4% increase
Employees
736
Employees
9,376
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
5.8 b
Valuation ($)
9.3 b
Facebook followers
Facebook followers
3.4 k
Facebook followers
661
Facebook followers
484
Facebook followers
5.3 k
Facebook followers
8.3 k
Twitter followers
Twitter followers
1.2 k
Twitter followers
842
Twitter followers
63
Twitter followers
1.9 k
Twitter followers
4.7 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$99.4m (FY, 2016)
Revenue (est.)
€2.1b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$45.2m (FY, 2016)
Cost of goods
€1b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$54.2m (FY, 2016)
Gross profit
€1.1b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($167.2m) (FY, 2016)
Net income
€179.2m (FY, 2016)

Funding

Latest funding round
Latest funding round
$ 9.9m (9 months ago)
Latest funding round
$ 36.6m (6 months ago)
Latest funding round
$ 40m (about 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 21.1m
Total funding raised
$ 36.6m
Total funding raised
$ 40m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles